United BioSource (UBC) Acquires Evidinno Outcomes Research
January 5, 2026
United BioSource LLC (UBC) has acquired Vancouver-based Evidinno Outcomes Research Inc., adding real-world evidence (RWE), epidemiology, evidence synthesis and HEOR capabilities to UBC's evidence-generation platform. Evidinno will operate as a wholly owned subsidiary of UBC; Fairmount Partners served as exclusive financial advisor to Evidinno.
- Buyers
- United BioSource LLC (UBC)
- Targets
- Evidinno Outcomes Research Inc.
- Industry
- Healthcare Services
- Location
- British Columbia, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Target RWE Acquires NoviSci Inc.
January 15, 2021
Healthcare Services
Target RWE, a Durham-based real-world evidence solutions company, has acquired NoviSci, Inc., a software analytics and services firm that applies epidemiologic methods and causal inference to health data. Amgen Inc. also made a strategic investment in the combined company, joining existing investors Norwest Venture Partners and 22C Capital to support growth; financial terms were not disclosed.
-
Red Nucleus Acquires Bridge Medical Consulting
February 5, 2026
Healthcare Services
Red Nucleus has acquired Bridge Medical Consulting, a UK-based health economics and outcomes research (HEOR) consultancy, to broaden its HEOR, real-world evidence, and market access capabilities for biopharmaceutical clients. The firm will be merged into Red Nucleus's existing HEOR business to expand evidence synthesis, economic modeling, RWE research, and AI-enabled workflows.
-
United BioSource (UBC) Acquires Examoto, LLC
July 28, 2022
Healthcare Services
United BioSource (UBC) has acquired Examoto, LLC, a provider of FDA-mandated REMS compliance platforms and risk-mitigation technology for the pharmaceutical industry. The acquisition expands UBC's REMS capabilities by combining Examoto's technology-driven REMS platform with UBC's scientific, safety, and commercialization services; terms were not disclosed.
-
Buenavista Equity Partners (via Evidenze) Acquires Chrestos Concept GmbH & Co. KG
November 22, 2024
Healthcare Services
Buenavista Equity Partners has acquired German CRO Chrestos Concept GmbH & Co. KG through its healthcare platform Evidenze Group Europe. The add-on expands Evidenze's capabilities in clinical trial design, biostatistics and data science and strengthens its presence in Germany as part of a buy-and-build strategy.
-
Datavant Acquires Aetion
July 13, 2025
Healthcare Services
Datavant has completed its acquisition of Aetion, bringing the real-world evidence (RWE) platform into Datavant’s Life Sciences business to create an end-to-end data feasibility and analysis offering. The deal combines Datavant’s data connectivity network with Aetion’s RWE analytics to expand capabilities for biopharma, device makers, payers, and regulators.
-
United BioSource (UBC) Acquires MarketShare Movers (MSM)
March 9, 2022
Healthcare Services
United BioSource LLC (UBC) has acquired MarketShare Movers (MSM), a data-driven prescription drug benefit and patient affordability company. The acquisition expands UBC's patient access and affordability capabilities by adding MSM's co-pay program execution, pharmacy adjudication, and proprietary analytics to UBC's patient access and commercialization services.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.